
By Mariam Sunny
(Reuters) -Global measles cases fell 71% to 11 million from the year 2000 to 2024, driven by improved vaccination coverage, the World Health Organization said in a report on Friday.
Vaccination has prevented nearly 59 million deaths globally during this period, according to the report.
Deaths dropped even more sharply by 88% to 95,000 in 2024, among the lowest annual tolls since 2000.
However, estimated cases in 2024 rose 8%, while deaths dropped 11%, compared with 2019 pre-pandemic levels, reflecting a shift in disease burden from low-income to middle-income countries, which have lower fatality ratios, the report said.
Measles is often the first disease to see a resurgence when vaccination coverage drops, the agency said, adding that growing measles outbreaks expose weaknesses in immunization programmes and health systems.
Due to its high transmissibility, "even small drops in vaccine coverage can trigger outbreaks, like a fire alarm going off when smoke is detected," said Kate O'Brien, director of the Department of Immunization at WHO.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Is Trump going to war with Venezuela? - 2
Farmers call for French blockades over cow disease cull - 3
Step by step instructions to Get the Best Vehicle Rent Arrangement: Insider Tips and Systems - 4
RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object. - 5
4 DSLR Cameras for Amateurs in 2024
Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
Travels to Dream Objections in Europe
Audits of 6 American Busssiness Class Flights
Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s
FBI arrests Brian Cole Jr. in Jan. 6 pipe bomb investigation, ending 5-year hunt
FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back?
Takeda's AI-crafted psoriasis pill succeeds in late-stage studies











